Top 10 Life Science Angel Investors in France in July 2025

Last updated: Jul 2025 A list of 10 angel investors that invest in Life science startups based in France. We rank investors based on the number of investments they made in Life science companies from France. We update this investor list every month.

Top 10 Life Science Angel Investors in France in July 2025

Investor	Life Science France investments
Andrew Nutter	2
Sylvain Zimmer	2
Jacques Lewiner	1
Irwan Bello	1
Christophe Ricard	1
Fidji Simo	1
Xavier Niel	1
Bernard Majoie	1
Sebastian Lombardo	1
Bertrand Jacquelot	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.

Investment focus

Software, SaaS, Biotechnology
Seed, Pre-Seed, Funding Round
France, United Kingdom, United States

Portfolio highlights

Yavin — Yavin provides modern point-of-sale solutions for European merchants
Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.

Sylvain is a French software developer turned entrepreneur, conference organizer and angel investor.

Investment focus

Software, Financial Services, SaaS
Seed, Pre-Seed, Angel
France, United States, United Kingdom

Portfolio highlights

GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.

Jacques Lewiner - Member of the Board of Directors @ Axilum Robotics

Investment focus

Biotechnology, Medical, Health Care
Seed, Series C
France

Portfolio highlights

Cytoo — Pioneering muscle pathology research with our exclusive MyoScreen platform to accelerate drug target identification and therapeutic innovation.
Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.

Irwan Bello is an individual investor.

Investment focus

Information Technology, Internet, Life Science
Seed, Pre-Seed
France, United States

Portfolio highlights

Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
Lutra AI — Lutra AI is to simplify complex tasks that specializes in workflows, created by the platform.
Twin — Agentic AI, made actionable.

Christophe Ricard CEO of OM Pharma

Investment focus

Life Science, Biotechnology, Medical Device
Seed, Series B
France

Portfolio highlights

Antabio — Antabio is a private biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.

Fidji Simo is the CEO and Chair of the Board of Directors of Instacart. She previously worked at Facebook as a Head of the Facebook App. Fidji Simo attended HEC Paris.

Investment focus

Software, Health Care, Internet
Seed, Series A, Series B
United States, United Kingdom, France

Portfolio highlights

Somite — Somite.ai is on a mission to transform the lives of millions of people by leveraging AI to produce human tissue for cell-based therapies.
Owner — Owner gives you the same tools that major national brands use to drive sales. Online ordering proven to grow sales. Mobile app with rewards. And more.
Orchid — Orchid is a reproductive technology startup that is capable of detecting rare genetic disorders. Orchid’s preconception system analyzes both partners’ genomes and assesses genetic predispositions to common diseases, including heart disease, stroke, schizophrenia, Alzheimer’s disease, breast cancer, and diabetes. Orchid results are developed withworld-class experts in reproductive medicine and genetics to give its clients the most accurate results.Orchid offers a “Couple Report” that utilizes an at-home saliva test to analyze each person’s genomes to detect the probability of genetic risks, then models how their DNA together will combine in a future child. If elevated risk is detected, Orchid provides insights to help couples monitor biomarkers, adapt their diet or elect for procedures, such as in vitro fertilization. It was founded by Noor Siddiqui in 2019 and is headquartered in San Francisco, California.

Xavier Niel is the Co-Founder and CEO of NJJ Capital. He previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.